News

UCB announced that it has received an Import Drug License (IDL) from the National Drug Administration of China (CNDA), creating a pathway to make VIMPAT (lacosamide) available to treat…
Read More...

IQVIA announced that Napo Pharmaceuticals, Inc. (Napo), a wholly-owned subsidiary of Jaguar Health, Inc., has selected Orchestrated Customer Engagement (OCE), IQVIA Technologies’…
Read More...

Autolus Therapeutics plc announced that the first patient has been dosed in its Phase 1/2 LibrA T1 clinical trial of AUTO4, a developmental therapy for the treatment of relapsed or…
Read More...

Merck announced that the European Commission has approved DELSTRIGO and PIFELTRO for the treatment of HIV-1 infection. DELSTRIGO is a new once-daily fixed-dose combination tablet of…
Read More...

AbCellera announced its collaboration with Autolus Therapeutics plc (Autolus), a clinical stage biopharmaceutical company developing next-generation programmed T cell therapies. Under…
Read More...

Telix Pharmaceuticals Limited and Nihon Medi-Physics Co., Ltd. have announced that they have signed a collaboration agreement to jointly evaluate the feasibility of 225Ac-labeled…
Read More...

Coeptis Pharmaceuticals announced that it has entered into a binding agreement to acquire all outstanding shares of Elto Pharma, Inc. Elto Phama is developing eltoprazine, a…
Read More...

TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and I-Mab Biopharma…
Read More...

Ajinomoto Bio-Pharma Services presented data at the World ADC Summit in San Diego this month describing a proprietary site-selective bioconjugation technology, AJICAP. The AJICAP…
Read More...

The U.S. Food and Drug Administration approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune…
Read More...

Generex Biotechnology Corporation announced the signing of a Letter of Intent to acquire 51 percent of Olaregen Therapeutix Inc., a New York based regenerative medicine company. Generex…
Read More...

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived…
Read More...

Catalent Pharma Solutions announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage and is…
Read More...

Aileron Therapeutics announced that it has entered into a clinical trial collaboration with Pfizer to evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s palbociclib, also…
Read More...

Evelo Biosciences announced that it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the US and Canada). The collaboration will evaluate…
Read More...

Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo …
Read More...

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be…
Read More...

AiPing Pharmaceutical, Inc. announced that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd.…
Read More...

Octapharma announced that the Swiss Agency for Therapeutic Products, Swissmedic, granted marketing authorization to its new fibrinogen concentrate product fibryga for the treatment of…
Read More...

CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) announced that they have entered into a clinical collaboration and license agreement to develop their…
Read More...